Beneficial and Adverse Effects of Molecularly Targeted Therapies for Acute Promyelocytic Leukemia in Central Nervous System

Publisher： Bentham Science Publishers

E-ISSN： 1996-3181|8|5|387-392

ISSN： 1871-5273

Source： CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders), Vol.8, Iss.5, 2009-11, pp. : 387-392

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Molecularly Targeted Therapies for Pediatric Acute Myeloid Leukemia: Progress to Date

By Brown Patrick Smith Franklin O.

Pediatric Drugs, Vol. 10, Iss. 2, 2008-01 ,pp. : 85-92

Adis International

Access to resources Recommend Favorite

New agents for acute myeloid leukemia: is it time for targeted therapies?

By Ferrara Felicetto

Expert Opinion on Investigational Drugs, Vol. 21, Iss. 2, 2012-02 ,pp. : 179-189

Informa Healthcare

Access to resources Recommend Favorite

Strategies for the Treatment of Acute Promyelocytic Leukemia

By Frankfurt Olga Tallman Martin S.

Journal of the National Comprehensive Cancer Network (JNCCN), Vol. 4, Iss. 1, 2006-01 ,pp. : 37-50

Cambridge Scholars Publishing in association with GSE Research

Access to resources Recommend Favorite

Prospects of Molecularly-Targeted Therapies for Cervical Cancer Treatment

Current Drug Targets, Vol. 16, Iss. 1, 2015-01 ,pp. : 77-91

Bentham Science Publishers

Access to resources Recommend Favorite

Targeted Delivery of Nano-Therapeutics for Major Disorders of the Central Nervous System

By Gao Huile Pang Zhiqing Jiang Xinguo

Pharmaceutical Research, Vol. 30, Iss. 10, 2013-10 ,pp. : 2485-2498

Springer Publishing Company

Access to resources Recommend Favorite